TrialPediatric nephrology (Berlin, Germany)2020

Rituximab for very low dose steroid-dependent nephrotic syndrome in children: a randomized controlled study.

Pietro Ravani et al.PubMed ↗Publisher ↗

No numbers read from the abstract.